The percent of chronic migraine patients who responded to onabotulinumtoxinA treatment per treatment cycle in the PREEMPT clinical program

被引：2
|
作者：
Silberstein, S. [1 ]
Dodick, D. W. [2 ]
DeGryse, R. E. [3 ]
Lipton, R. [4 ]
Turkel, C. C. [3 ]
机构：
[1] Thomas Jefferson Univ, Philadelphia, PA 19107 USA
[2] Mayo Clin Arizona, Phoenix, AZ USA
[3] Allergan Pharmaceut Inc, Irvine, CA 92715 USA
[4] Albert Einstein Coll Med, Bronx, NY 10467 USA
来源：
JOURNAL OF HEADACHE AND PAIN | 2013年 / 14卷
关键词：
Migraine; Treatment Cycle; Chronic Migraine; Migraine Patient; Responder Rate;
D O I：
10.1186/1129-2377-14-S1-P200
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Consecutive Headache-Free Days With OnabotulinumtoxinA Treatment in Patients With Chronic Migraine: A Pooled PREEMPT Analysis
    Diener, H. C.
    Dodick, D. W.
    Lipton, R. B.
    Sommer, K.
    Silberstein, S. D.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 105 - 105
  • [22] Clinical trials on onabotulinumtoxinA for the treatment of chronic migraine
    Russell, Michael Bjorn
    JOURNAL OF HEADACHE AND PAIN, 2011, 12 (02): : 135 - 136
  • [23] Clinical trials on onabotulinumtoxinA for the treatment of chronic migraine
    Michael Bjørn Russell
    The Journal of Headache and Pain, 2011, 12 : 135 - 136
  • [24] Consecutive Headache-Free Days With OnabotulinumtoxinA Treatment in Patients With Chronic Migraine: A Pooled PREEMPT Analysis
    Diener, Hans-Christoph
    Dodick, David W.
    Lipton, Richard B.
    Sommer, Katherine
    Silberstein, Stephen D.
    NEUROLOGY, 2021, 96 (15)
  • [25] Consecutive Headache-Free Days With OnabotulinumtoxinA Treatment in Patients With Chronic Migraine: A Pooled PREEMPT Analysis
    Diener, H. C.
    Dodick, D. W.
    Lipton, R. B.
    Sommer, K.
    Silberstein, S. D.
    CEPHALALGIA, 2021, 41 (1_SUPPL) : 155 - 156
  • [26] OnabotulinumtoxinA Treatment Improves Quality of Life in Patients with Chronic Migraine (CM): MSQ Results from PREEMPT
    Silberstein, S. D.
    Varon, S. F.
    Diener, H. -C.
    DeGryse, R. E.
    Turkel, C. C.
    HEADACHE, 2010, 50 : S30 - S31
  • [27] Consecutive Headache-Free Days With OnabotulinumtoxinA Treatment in Patients With Chronic Migraine: A Pooled PREEMPT Analysis
    Diener, Hans-Christoph
    Dodick, David W.
    Lipton, Richard B.
    Sommer, Katherine
    Silberstein, Stephen D.
    TOXICON, 2022, 214 : S15 - S16
  • [28] Consecutive headache-free days with OnabotulinumtoxinA treatment in patients with chronic migraine: A pooled PREEMPT analysis
    Diener, H. C.
    Dodick, D. W.
    Lipton, R. B.
    Sommer, K.
    Silberstein, S. D.
    HEADACHE, 2021, 61 : 117 - 117
  • [29] Sustained Benefits of OnabotulinumtoxinA Treatment in Chronic Migraine: Results from a PREEMPT Pooled Analysis
    Silberstein, Stephen
    Diener, Hans-Christoph
    Dodick, David
    Yedigarova, Larisa
    Lipton, Richard
    NEUROLOGY, 2020, 94 (15)
  • [30] Sustained Benefits of OnabotulinumtoxinA Treatment in Chronic Migraine: Results from a PREEMPT Pooled Analysis
    Silberstein, S.
    Diener, H. -C.
    Dodick, D.
    Luo, L.
    Yedigarova, L.
    Lipton, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 444 - 444
12345